Samuel Isaly (Trades, Portfolio), manager of the Eaton Vance Worldwide Health Care Fund (ETHSX), invested in three health care companies and eliminated his position in three others during the second quarter of 2016. An active health care investor, Isaly seeks long-term capital growth in health care companies that have potential for high growth and increased market share. The portfolio manager generally has 80% of his assets in health sciences industries, including biotechnology, pharmaceuticals and medical equipment.
The ETHSX portfolio manager made three new buys during the second quarter: Biomarin Pharmaceutical Inc. (NASDAQ:BMRN), UnitedHealth Group Inc. (NYSE:UNH) and Medivation Inc. (NASDAQ:MDVN). Among these three stocks, Isaly made the largest investment in Biomarin: during the second quarter, the manager purchased 370,500 shares at an average price of $85.12. Additionally, Isaly purchased 292,900 shares of Medivation at an average price of $49.98 and 177,300 shares of UnitedHealth at an average price of $129.10. Continue Reading »